Living with cancer can be tough. Particularly when you’re suffering with peripheral neurpathy. Reflexology in the management of chemotherapy-induced neuropathy: A pilot randomized controlled trial Author links open overlay panel Seda Kurta Gul Beyaz Canb

Highlights

• Chemotherapy-induced peripheral neuropathy (CIPN) can limit a patient’s quality of life functions.

• Reflexology increases the level of the quality of life functions related to CIPN.

• Reflexology can be recommended to the patients.

Abstract Purpose

The current experimental study aimed to evaluate the effectiveness of reflexology on the management of symptoms and functions of chemotherapy-induced peripheral neuropathy (CIPN) in cancer patients.

Method

This study was conducted as a randomized controlled trial in 60 patients (30 experimental and 30 control patients) who had chemotherapy-induced Grade II-IV peripheral neuropathy complaints from July 2013 to November 2015. Data were collected using the patient identification form, European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire Chemotherapy-Induced Peripheral Neuropathy (EORTC-CIPN-20) form, and BPI (used for related chemotherapy-induced peripheral neuropathy symptoms).

Results

The majority of the patients were being treated for gastrointestinal or breast cancer and were primarily receiving Eloxatine- or taxane-based treatment. It was found that reflexology applications did not lead to differences in either group in terms of peripheral neuropathy severity and incidence (p > 0.05) and only led to improvement in sensory functions in the experimental group (p < 0.05).

Conclusions

It was determined that reflexology is an effective method in the management of patients’ sensory functions related to CIPN.

Elsevier European Journal of Oncology Nursing Volume 32, February 2018, Pages 12-19 European Journal of Oncology Nursing

Contact us now

Interested how to help cancer? Read about garlic benefits.